March 19, 2020 / 6:52 AM / 17 days ago

BRIEF-Geneuro Postpones Phase 2 Multiple Sclerosis Trial

March 19 (Reuters) - Geneuro SA:

* GENEURO PHASE 2 MULTIPLE SCLEROSIS TRIAL UPDATE

* TEMPORARY POSTPONEMENT OF PLANNED PHASE 2 TRIAL OF TEMELIMAB IN MULTIPLE SCLEROSIS AT KAROLINSKA INSTITUTET’S ACADEMIC SPECIALIST CENTER (ASC), STOCKHOLM, SWEDEN

* ONE-YEAR TRIAL WILL ENROLL PATIENTS WHOSE DISABILITY PROGRESSES WITHOUT RELAPSES

* INITIATION OF TRIAL WILL NOW TAKE PLACE ONCE HOSPITALS HAVE MORE CAPACITIES FOR CLINICAL RESEARCH AND ARE ABLE TO ENSURE THAT MS PATIENTS WILL NOT BE PUT AT RISK-CEO

* WE MUST PUT FIGHT AGAINST COVID-19 AND SAFETY OF MS PATIENTS FIRST-CEO

* POSTPONEMENT TO PRIORITIZE HEALTHCARE RESOURCES BEHIND FIGHT OF COVID-19 AND TO REDUCE RISK FOR MS PATIENTS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below